"Promising Activity" Of Cetuximab In Patients With Advanced Biliary Cancer

BARCELONA, SPAIN—Adding cetuximab to gemcitabine/oxaliplatin (GEMOX) chemotherapy controlled disease among two thirds of patients with advanced biliary cancer in a trial reported at the World Congress on Gastrointestinal Cancer. Éveline Boucher from the Centre Eugene Marquis, in Rennes, France, presented preliminary findings from a phase II open-label study among 101 patients who had not already received palliative treatment for their advanced biliary cancers, and had WHO performance status 0-1. She discussed her team’s findings with Peter Goodwin.

You can listen to "Promising Activity" Of Cetuximab In Patients With Advanced Biliary Cancer online on Radio and Podcast. Open the player on this page to stream the available audio.

"Promising Activity" Of Cetuximab In Patients With Advanced Biliary Cancer is an episode from Oncology Times Broadcast News.

This episode is 00:02:18 long.

This episode was published on Sep 28, 2009.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Oncology Times Broadcast News when more episodes are available from the podcast feed.